
News|Podcasts|July 30, 2025
Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC
Kevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Zilganersen Injection, First Drug for Alexander Disease
2
AAP Issues 2026-2027 Guidance on RSV and COVID-19 Immunization
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
Fast-Acting Meloxicam Demonstrates Postoperative Pain Relief and Opioid-Sparing Potential
5


































































































